Viral Triggers in Pediatric Lung Transplantation
Completed
Conditions studied: Lung Transplant, Bronchiolitis Obliterans, Obliterative Bronchiolitis
In brief
The purpose of this study is to determine whether respiratory viral infections increase the risk of bronchiolitis obliterans syndrome (BOS), obliterative bronchiolitis (OB), death, or retransplantation in children who have received lung transplants.
Key facts
- Study ID
- NCT00891865
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 61
- Starts
- 2009-06-01
- Expected to finish
- 2015-04-01
- Last updated by the study team
- 2020-07-02
Who can join
Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Parent or legal guardian willing and able to provide informed consent
- Participant of first single or bilateral heart-lung transplant
You may not qualify if…
- Recipient of multi-organ transplant (aside from heart-lung)
- Condition or characteristic which in the opinion of the investigator makes the participant unlikely to complete the study
Where it is running
- Stanford University — Palo Alto, California, United States
- Children's Hospital Boston — Boston, Massachusetts, United States
- Washington University — St Louis, Missouri, United States
- Nationwide Children's Hospital — Columbus, Ohio, United States
- Children's Hospital of Pennsylvania — Philadelphia, Pennsylvania, United States
- Texas Children's Hospital — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.